Literature DB >> 17588744

Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.

Shoukou Lee1, Chihiro Shinji, Kiyoshi Ogura, Motomu Shimizu, Satoko Maeda, Mayumi Sato, Minoru Yoshida, Yuichi Hashimoto, Hiroyuki Miyachi.   

Abstract

We designed and synthesized hydroxamic acid derivatives bearing a 4-(3-pyridyl)phenyl group as a cap structure, and found that they exhibit potent histone deacetylase (HDAC) inhibitory activity. A representative compound, 17a, showed more potent growth-inhibitory activity against pancreatic cancer cells and greater upregulation of p21(WAF1/CIP1) expression than the clinically used HDAC inhibitor suberoylanilide hydroxamic acid (Zolinza).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588744     DOI: 10.1016/j.bmcl.2007.06.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

Review 1.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

2.  Synthesis, anti-inflammatory, and antiproliferative activity evaluation of isoindole, pyrrolopyrazine, benzimidazoisoindole, and benzimidazopyrrolopyrazine derivatives.

Authors:  Sandeep Kumar; Nikhil Kumar; Partha Roy; Sham M Sondhi
Journal:  Mol Divers       Date:  2013-08-27       Impact factor: 2.943

3.  Highly Regioselective Synthesis of Substituted Isoindolinones via Ruthenium-Catalyzed Alkyne Cyclotrimerizations.

Authors:  Robert W Foster; Christopher J Tame; Helen C Hailes; Tom D Sheppard
Journal:  Adv Synth Catal       Date:  2013-08-12       Impact factor: 5.837

4.  Synthesis of spiro[isoindole-1,5'-isoxazolidin]-3(2H)-ones as potential inhibitors of the MDM2-p53 interaction.

Authors:  Salvatore V Giofrè; Santa Cirmi; Raffaella Mancuso; Francesco Nicolò; Giuseppe Lanza; Laura Legnani; Agata Campisi; Maria A Chiacchio; Michele Navarra; Bartolo Gabriele; Roberto Romeo
Journal:  Beilstein J Org Chem       Date:  2016-12-20       Impact factor: 2.883

5.  Hydroxamic acid - A novel molecule for anticancer therapy.

Authors:  Dilipkumar Pal; Supriyo Saha
Journal:  J Adv Pharm Technol Res       Date:  2012-04

6.  Unprecedented selective homogeneous cobalt-catalysed reductive alkoxylation of cyclic imides under mild conditions.

Authors:  Jose R Cabrero-Antonino; Rosa Adam; Veronica Papa; Mattes Holsten; Kathrin Junge; Matthias Beller
Journal:  Chem Sci       Date:  2017-06-12       Impact factor: 9.825

7.  Iridium(I)-Catalyzed Isoindolinone-Directed Branched-Selective Aromatic C-H Alkylation with Simple Alkenes.

Authors:  Maoqian Xiong; Yuhang Shu; Jie Tang; Fan Yang; Dong Xing
Journal:  Molecules       Date:  2022-03-16       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.